ADMA Biologics Receives a Split FDA Decision on BIVIGAM

By |2018-12-20T15:03:58-05:00December 20th, 2018|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: , , |

ADMA Biologics (NASDAQ:ADMA), a company specializing in the manufacturing and development [...]